Friends and colleagues, Stanford nephrology fellows Daniel Watford and Dimitri Augustin trained alongside each other in Florida and then both moved west.
My legs were starting to ache from standing by my research poster for nearly ten hours. At 15, I was anxiously awaiting the possibility to …
A Stanford physician discusses how he's learned to safely manage intense situations with patients in emergency departments.
Many early clinical studies of COVID-19 fail to meet quality standards, raising concerns that the data could be of little meaningful use, research finds.
Stanford postdoc Brielle Ferguson helped to organize a project called 'Black in Neuro Week' to amplify Black scientists in neuroscience.
After treating a patient with an unusual ammonia metabolism problem, a Stanford researcher assembled a team to reimagine ammonia blood testing.
Stanford-led research finds that the blood-brain barrier may be much more permeable -- albeit selectively so -- than previously thought.
Rep. John Lewis, who died July 17, 2020, was interviewed in April 2019 for a Stanford Medicine course on leadership and finding moral identity.
Stanford researchers and colleagues have invented a genetic safety mechanism that can deactivate transplanted cells if they change in a problematic way.
Experts from the Stanford Caregiver Center offer help for people doing the sometimes overwhelming work of caring for ill or vulnerable loved ones.
A Stanford researcher discusses how toxic pollutants can make people more susceptible to COVID-19 and why people of color are particularly vulnerable.
In the Spotlight: Stanford medical student Claire Rhee decided to take a stand on social justice long before she chose to pursue a career in medicine.
Through a survey, an initiative and a speed-mentoring event, the Stanford Byers Center for Biodesign is taking on gender inequalities in health tech.
Stanford-led research examines state rules allowing dispensaries to make erroneous claims about the effectiveness of cannabis in treating opioid addiction.
People taking two common types of drugs for hypertension are at no heightened risk, as has been feared, for increased severity or complications of COVID-19.
A new white paper from Stanford Medicine and the Bill Lane Center for the American West explores the challenges and promise of telehealth solutions.